© 1993 Oxford University Press
editorial |
Characterization of p53 mutations in methylene chloride-induced lung tumors from B6C3F1 mice
Laboratory of Molecular Carcinogenesis NIH, PO Box 12233, Research Triangle Park, NC 27709
1Laboratory of Chemical Pathology NIH, PO Box 12233, Research Triangle Park, NC 27709
3Laboratory of Systemic Toxicity NIH, PO Box 12233, Research Triangle Park, NC 27709
4Laboratory of Molecular Toxicology, National Institute of Environmental Health Sciences NIH, PO Box 12233, Research Triangle Park, NC 27709
2Department of Environmental Sciences and Engineering, School of Public Health, University of North Carolina Chapel Hill, NC 27599, USA
Abstract
Mutations of the p53 tumor suppressor gene are the most common defined genetic alterations seen in a wide variety of human cancers. In contrast, little is known about the importance of the p53 gene in chemically induced tumors of rodents, which are widely used as models for the evaluation of human health risks. In this study we examined 54 methylene chloride-induced and seven spontaneously arising lung tumors from female B6C3F1 mice for losses of heterozygosity (LOH) at markers near the p53 gene on chromosome 11. LOH was detected in seven methylene chloride-induced lung carcinomas by Southern analysis of a restriction fragment length polymorphism and PCR analysis of five simple sequence length polymorphisms. In each case allele loss was observed at all six markers; thus, these chromosomal alterations were likely to have resulted from mitotic nondisjunction. In contrast, LOH was not detected in 20 liver tumors from methylene chloride-treated mice at the Acrb locus, which is tightly linked to the p53 gene on chromosome 11. In addition single strand conformation polymorphism analysis was performed to screen for mutations in the most conserved regions of the p53 gene (exons 5 to 8). Consequently, potential mutations identified by direct sequencing, were only detected in four of the seven tumor samples with LOH, but not in any of the remaining lung tumors. Overexpression of the p53 protein by immuno-histochemical staining was detected only in the four tumors that contained p53 point mutations and in a focal area of another tumor. Finally, using a simple sequence length polymorphism within the retinoblastoma tumor suppressor gene, LOH on mouse chromosome 14 was also detected in three lung carcinomas and one liver tumor. Inactivation of p53 and possibly the retinoblastoma tumor suppressor gene appear to be infrequent events in lung and liver tumors from methylene chloride treated mice.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  H.-H. L. Hong, T.-V. T. Ton, Y. Kim, N. Wakamatsu, N. P. Clayton, P.-C. Chan, R. C. Sills, and S. A. Lahousse Genetic Alterations in K-ras and p53 Cancer Genes in Lung Neoplasms from B6C3F1 Mice Exposed to Cumene Toxicol Pathol, July 1, 2008; 36(5): 720 - 726. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Annual Review of Cosmetic Ingredient Safety Assessments: 2005/2006 International Journal of Toxicology, January 1, 2008; 27(1_suppl): 77 - 142. [Full Text] [PDF]
|
|
|
|
 |
|
 B. I. Ghanayem Inhibition of Urethane-Induced Carcinogenicity in Cyp2e1-/- in Comparison to Cyp2e1+/+ Mice Toxicol. Sci., February 1, 2007; 95(2): 331 - 339. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Wakamatsu, T. R. devereux, H.-H. L. Hong, and R. C. Sills Overview of the Molecular Carcinogenesis of Mouse Lung Tumor Models of Human Lung Cancer Toxicol Pathol, January 1, 2007; 35(1): 75 - 80. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Jackson, I. Lea, A. Rashid, S. D. Peddada, and J. K. Dunnick Genetic Alterations in Cancer Knowledge System: Analysis of Gene Mutations in Mouse and Human Liver and Lung Tumors Toxicol. Sci., April 1, 2006; 90(2): 400 - 418. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. C. Pulling, B. R. Vuillemenot, J. A. Hutt, T. R. Devereux, and S. A. Belinsky Aberrant Promoter Hypermethylation of the Death-Associated Protein Kinase Gene Is Early and Frequent in Murine Lung Tumors Induced by Cigarette Smoke and Tobacco Carcinogens Cancer Res., June 1, 2004; 64(11): 3844 - 3848. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. R. Vuillemenot, L. C. Pulling, W. A. Palmisano, J. A. Hutt, and S. A. Belinsky Carcinogen exposure differentially modulates RAR-{beta} promoter hypermethylation, an early and frequent event in mouse lung carcinogenesis Carcinogenesis, April 1, 2004; 25(4): 623 - 629. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.C. Sills, H.L. Hong, G. Flake, C. Moomaw, N. Clayton, G.A. Boorman, J. Dunnick, and T.R. Devereux o-Nitrotoluene-induced large intestinal tumors in B6C3F1 mice model human colon cancer in their molecular pathogenesis Carcinogenesis, April 1, 2004; 25(4): 605 - 612. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.R. Maronpot, G. Flake, and A. J. Huff Relevance of Animal Carcinogenesis Findings to Human Cancer Predictions and Prevention Toxicol Pathol, January 1, 2004; 32(1_suppl): 40 - 48. [Abstract] [PDF]
|
|
|
|
 |
|
 B. Govindarajan, M. C. Mizesko, M. S. Miller, H. Onda, M. Nunnelly, K. Casper, D. Brat, C. Cohen, and J. L Arbiser Tuberous Sclerosis-associated Neoplasms Express Activated p42/44 Mitogen-activated Protein (MAP) Kinase, and Inhibition of MAP Kinase Signaling Results in Decreased in Vivo Tumor Growth Clin. Cancer Res., August 1, 2003; 9(9): 3469 - 3475. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Sargent, J. R. Senft, D. T. Lowry, A. M. Jefferson, F. L. Tyson, A. M. Malkinson, A. E. Coleman, and S. H. Reynolds Specific Chromosomal Aberrations in Mouse Lung Adenocarcinoma Cell Lines Detected by Spectral Karyotyping: A Comparison with Human Lung Adenocarcinoma Cancer Res., February 1, 2002; 62(4): 1152 - 1157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Takagi, T. Matsuzaki, M. Sato, K. Nomoto, M. Morotomi, and T. Yokokura Enhancement of natural killer cytotoxicity delayed murine carcinogenesis by a probiotic microorganism Carcinogenesis, April 1, 2001; 22(4): 599 - 605. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. French, G. D. Lacks, C. Trempus, J. K. Dunnick, J. Foley, J. Mahler, R. R. Tice, and R. W. Tennant Loss of heterozygosity frequency at the Trp53 locus in p53-deficient (+/-) mouse tumors is carcinogen-and tissue-dependent Carcinogenesis, January 1, 2001; 22(1): 99 - 106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-H. L. Hong, T. R. Devereux, R. L. Melnick, C. R. Moomaw, G. A. Boorman, and R. C. Sills Mutations of ras Protooncogenes and p53 Tumor Suppressor Gene in Cardiac Hemangiosarcomas from B6C3F1 Mice Exposed to 1,3-Butadiene for 2 Years Toxicol Pathol, July 1, 2000; 28(4): 529 - 534. [Abstract] [PDF]
|
|
|
|
|
|
M. E. Hegi, M. A. Klein, D. Ruedi, P. Chene, M.-F. Hamou, and A. Aguzzi p53 Transdominance But No Gain of Function in Mouse Brain Tumor Model Cancer Res., June 1, 2000; 60(11): 3019 - 3024. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Gulezian, D. Jacobson-Kram, C. B. Mccullough, H. Olson, L. Recio, D. Robinson, R. Storer, R. Tennant, J. M. Ward, and D. A. Neumann Review Article: Use of Transgenic Animals for Carcinogenicity Testing: Considerations and Implications for Risk Assessment Toxicol Pathol, May 1, 2000; 28(3): 482 - 499. [Abstract] [PDF]
|
|
|
|
|
|
Z. Zhang, Q. Liu, L. E. Lantry, Y. Wang, G. J. Kelloff, M. W. Anderson, R. W. Wiseman, R. A. Lubet, and M. You A Germ-Line p53 Mutation Accelerates Pulmonary Tumorigenesis: p53-independent Efficacy of Chemopreventive Agents Green Tea or Dexamethasone/myo-Inositol and Chemotherapeutic Agents Taxol or Adriamycin Cancer Res., February 1, 2000; 60(4): 901 - 907. [Abstract] [Full Text]
|
|
|
|
|
|
A. S. Tam, J. F. Foley, T. R. Devereux, R. R. Maronpot, and T. E. Massey High Frequency and Heterogeneous Distribution of p53 Mutations in Aflatoxin B1-induced Mouse Lung Tumors Cancer Res., August 1, 1999; 59(15): 3634 - 3640. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. L. Finch, T. H. March, F. E. Hahn, E. B. Barr, S. A. Belinsky, M. D. Hoover, J. E. Lechner, K. J. Nikula, and C. H. Hobbs Carcinogenic Responses of Transgenic Heterozygous p53 Knockout Mice to Inhaled 239PuO2 or Metallic Beryllium Toxicol Pathol, July 1, 1998; 26(4): 484 - 491. [Abstract] [PDF]
|
|
|
|
|
|
L. S. Trukhanova, H.-H. L. Hong, R. C. Sills, A. D. Bowser, B. Gaul, G. A. Boorman, V. S. Turusov, T. R. Devereux, and D. Dixon Predominant p53 G->A Transition Mutation and Enhanced Cell Proliferation in Uterine Sarcomas of CBA Mice Treated with 1,2-Dimethylhydrazine Toxicol Pathol, May 1, 1998; 26(3): 367 - 374. [Abstract] [PDF]
|
|
|
|
|
|
J. K. Dunnick, J. F. Hardisty, R. A. Herbert, J. C. Seely, E. M. Furedi-Machacek, J. F. Foley, G. D. Lacks, S. Stasiewicz, and J. E. French Phenolphthalein Induces Thymic Lymphomas Accompanied by Loss of the p53 Wild Type Allele in Heterozygous p53-Deficient ({+/-}) Mice Toxicol Pathol, November 1, 1997; 25(6): 533 - 540. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Nilsson, A. B. Unden, D. Krause, U. Malmqwist, K. Raza, P. G. Zaphiropoulos, and R. Toftgard Induction of basal cell carcinomas and trichoepitheliomas in mice overexpressing GLI-1 PNAS, March 28, 2000; 97(7): 3438 - 3443. [Abstract] [Full Text] [PDF]
|
|